CAMBRIDGE, Mass., March 23, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, chair and chief executive officer, will be presenting a company overview at the 16th Annual Future Leaders in the Biotech Industry Conference. Infinity's presentation will take place on Thursday, April 2, 2009 at 2:30 p.m. (EDT) at the Millennium Broadway Hotel in New York City.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.infi.com.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.